We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05597085
Brief Title: A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

First Submitted : October 24, 2022
First Submitted that Met QC Criteria : October 24, 2022
First Posted : October 27, 2022

Last Update Submitted that Met QC Criteria : November 3, 2022
Last Update Posted : November 7, 2022